Treatment Effects of the Integrated Perinatal Diabetes Education and Management Program.

Q3 Medicine

Diabetes Spectrum Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI:10.2337/ds24-0076

Loral Patchen, Asli McCullers, Serenity Budd, Melanie Browning, Shrey Mathur, Kristopher Wu, Rebecca Dills, Stacee Silagi, Jennifer Welch, Victoria Greenberg

{"title":"Treatment Effects of the Integrated Perinatal Diabetes Education and Management Program.","authors":"Loral Patchen, Asli McCullers, Serenity Budd, Melanie Browning, Shrey Mathur, Kristopher Wu, Rebecca Dills, Stacee Silagi, Jennifer Welch, Victoria Greenberg","doi":"10.2337/ds24-0076","DOIUrl":null,"url":null,"abstract":"Objective: The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) was launched to improve outcomes of pregnant and postpartum individuals with diabetes at a large, urban academic hospital system. The purpose of this study was to evaluate treatment outcomes achieved by program participants.Research design and methods: This retrospective cohort study compared diabetes treatment received by participants in the IP-DEMP with diabetes treatment in a historical comparison group at the same health care facility just before implementation of the IP-DEMP. Logistic regression was used to model the association of participation in the intervention with treatment, adjusting for covariates.Results: A total of 355 people were included in the analysis. Descriptive characteristics were similar between the intervention and comparison groups. Among participants with gestational diabetes mellitus (GDM), participation in the intervention group significantly increases the likelihood of receiving insulin, the gold-standard therapy during pregnancy. No significant differences in therapy received were observed among participants with different racial and ethnic identities.Conclusion: People with GDM who participated in the IP-DEMP were more likely to receive insulin therapy. Treatment received was not different for participants from historically marginalized groups.","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 3","pages":"321-326"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357190/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/ds24-0076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The Integrated Perinatal Diabetes Education and Management Program (IP-DEMP) was launched to improve outcomes of pregnant and postpartum individuals with diabetes at a large, urban academic hospital system. The purpose of this study was to evaluate treatment outcomes achieved by program participants.

Research design and methods: This retrospective cohort study compared diabetes treatment received by participants in the IP-DEMP with diabetes treatment in a historical comparison group at the same health care facility just before implementation of the IP-DEMP. Logistic regression was used to model the association of participation in the intervention with treatment, adjusting for covariates.

Results: A total of 355 people were included in the analysis. Descriptive characteristics were similar between the intervention and comparison groups. Among participants with gestational diabetes mellitus (GDM), participation in the intervention group significantly increases the likelihood of receiving insulin, the gold-standard therapy during pregnancy. No significant differences in therapy received were observed among participants with different racial and ethnic identities.

Conclusion: People with GDM who participated in the IP-DEMP were more likely to receive insulin therapy. Treatment received was not different for participants from historically marginalized groups.

查看原文本刊更多论文

围产期糖尿病综合教育与管理方案的治疗效果。

目的：开展围产期糖尿病综合教育和管理项目（IP-DEMP），以改善大型城市学术医院系统妊娠和产后糖尿病患者的预后。本研究的目的是评估项目参与者的治疗效果。研究设计和方法：这项回顾性队列研究比较了IP-DEMP参与者接受的糖尿病治疗与实施IP-DEMP之前同一医疗机构的历史对照组的糖尿病治疗。采用逻辑回归对参与干预与治疗的关系进行建模，调整协变量。结果：共有355人被纳入分析。描述性特征在干预组和对照组之间相似。在患有妊娠期糖尿病（GDM）的参与者中，干预组的参与显著增加了接受胰岛素治疗的可能性，这是妊娠期间的金标准治疗。不同种族和民族身份的参与者在接受治疗方面没有显著差异。结论：参加IP-DEMP的GDM患者更有可能接受胰岛素治疗。来自历史上被边缘化群体的参与者所接受的治疗并没有什么不同。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes Spectrum Medicine-Internal Medicine

CiteScore

2.70

自引率

0.00%

发文量

期刊介绍： The mission of Diabetes Spectrum: From Research to Practice is to assist health care professionals in the development of strategies to individualize treatment and diabetes self-management education for improved quality of life and diabetes control. These goals are achieved by presenting review as well as original, peer-reviewed articles on topics in clinical diabetes management, professional and patient education, nutrition, behavioral science and counseling, educational program development, and advocacy. In each issue, the FROM RESEARCH TO PRACTICE section explores, in depth, a diabetes care topic and provides practical application of current research findings.